The global percutaneous coronary intervention market is anticipated to reach USD 16.7 billion by 2020 growing at a CAGR of 7.2% during the forecasting period, 2020-2028. Percutaneous Coronary Intervention is a non-invasive procedure that is used for treating the narrowing arteries of the heart in coronary artery diseases including angina, acute myocardial infarction, and multivessel coronary artery disease (CAD). Factors such as rising risk factors associated with heart diseases such as obesity, smoking, and substance abuse, fatty foods, etc and rising geriatric and pediatric population are some of the major drivers for the market of percutaneous coronary intervention.
The global percutaneous coronary intervention market is segmented into type, technique, disease, end-user, and geography.
The type segment is segmented into Balloon Angioplasty, Angioplasty with Stent, Laser Angioplasty, Rotational Atherectomy, CTO (Chronic Total Occlusions), Coronary Guidewires, Coronary Stents, PTCA Catheters, Embolic Protection Devices (EPDs). Balloon Angioplasty segment is further segmented into Aorta, Iliac Artery, Femoral Artery, Popliteal Artery, Tibial and Peroneal Arteries. Angioplasty with Stent is further segmented into Dual Therapy Stent, Bioresorbable Vascular Scaffold, Bio-Engineered Stent, Drug-Eluting Stent, and bare-metal stent. The Rotational Atherectomy segment is further segmented into Low-Speed Rotational Atherectomy, High-Speed Rotational Atherectomy. CTO (Chronic Total Occlusions) segment is further segmented into Retrograde Technique, Anterograde Technique with Wire Scaling, Anterograde Dissection, and Reentry Technique and Others.
Techniques are segmented into Advanced Imaging, Fractional Flow Reserve (FRR), and Radial Artery Access
The disease is segmented into Angina, Myocardial Infraction (MI), Multivessel Coronary Artery Disease (CAD). Angina is further segmented into Unstable Angina, Stable Angina. Myocardial Infraction is further segmented into Acute Non-ST Elevation Myocardial Infarction, Acute ST-Elevation Myocardial Infarction. Multivessel Coronary Artery Disease is further segmented into Obstructive Coronary Artery Disease and Spontaneous Coronary Artery Dissection (SCAD).
End-User is segmented into Hospital, Cardiac Centers, Ambulatory Surgical Centers, Specialty Centers, Cath Labs, and Others
Geographically, the global percutaneous coronary intervention market is sub-segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America and insights are provided for each region and major countries within the regions
North America region is the largest contributor to the percutaneous coronary intervention market in the forecast period 2020-2028.
Key players in global percutaneous coronary intervention market Abbott, Asahi Intecc Company Limited, B. Braun Melsungen AG, Biosensors International Group, Ltd., Biotronik, Boston Scientific Corporation, C. R. Bard, Inc., Comed B.V., Cook, Cordis, Medtronic, Merit Medical System, Terumo Corporation, Philips Healthcare among others
The companies have come up with various promotional activities in from of launch, investment, acquisition, and other, for instance:
|
Report Features |
Description |
|---|---|
|
Market Revenue In 2020 |
USD 16.7 billion |
|
Growth Rate |
CAGR of 7.9% during the forecasting period, 2020-2028 |
|
Historical Data |
2017-2018 |
|
Forecast Years |
2020-2028 |
|
Base Year |
2019 |
|
Units Considered |
Revenue in USD billion and CAGR from 2020 to 2028 |
|
Report Segmentation |
Type, Technique, Disease, End-User, and Geography |
|
Report Attribute |
Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling |
|
Regional Level Scope |
North America, Europe, Asia-Pacific, South America, and the Middle East and Africa |
|
Country Level Scope |
U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe) |
|
Companies Profiled |
Abbott, Asahi Intecc Company Limited, B. Braun Melsungen AG, Biosensors International Group, Ltd., Biotronik, Boston Scientific Corporation, C. R. Bard, Inc., Comed B.V., Cook, Cordis, Medtronic, Merit Medical System, Terumo Corporation, Philips Healthcare among others |
|
Available Customization |
In addition to the market data for the percutaneous coronary intervention market, Delvens. offers client-centric reports and customized according to the company’s specific demand and requirement. |
.png)
.png)
.png)
.png)
.png)
.png)